Jessica dos Santos and Leo Joosten, theme Infectious diseases and global health, and colleagues, describe in Cell Reports that trained immunity induced by b-glucan confers protection against L. braziliensis infections. Infection control is associated with IL-32 and IL-1 induction. Genetic variation in the IL-32 gene enhances induction of trained immunity leading to proinﬂammatory gene transcription in bone marrow hematopoietic stem and progenitor cells.
American tegumentary leishmaniasis is a vector-borne parasitic disease caused by Leishmania protozoans. Innate immune cells undergo long-term functional reprogramming in response to infection or Bacillus Calmette-Guerin (BCG) vaccination via a process called trained immunity, conferring non-speciﬁc protection from secondary infections. They demonstrate that monocytes trained with the fungal cell wall component b-glucan confer enhanced protection against infections caused by Leishmania braziliensis through the enhanced production of proinﬂammatory cytokines. Mechanistically, this augmented immunological response is dependent on increased expression of interleukin 32 (IL-32). Studies performed using a humanized IL-32 transgenic mouse highlight the clinical implica-tions of these ﬁndings in vivo. This study represents a deﬁnitive characterization of the role of IL-32g in the trained phenotype induced by b-glucan or BCG, the results of which improve the understanding of the molecular mechanisms governing trained immunity and Leishmania infection control.
Related news items
Online intervention for women exposed to intimate partner violence21 November 2019
Within the SAFE project from the department of Primary and Community Care an eHealth intervention has been developed for women exposed to intimate partner violence (IPV).read more
A personal touch of Sander Leeuwenburgh21 November 2019
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Sander Leeuwenburgh.read more
Technology for Oncology II grant application funded21 November 2019
The grant application called "aiREAD – Accurate and Intelligent Reading for EArlier breast cancer Detection” by project leader Ioannis Sechopoulos, has been selected for funding under the NWO TTW – KWF Kankerbestrijding – Top Sector LSH Partnership “Technology for Oncology II”.read more
KNCV Golden Master Award call for nominations20 November 2019
The Royal Netherlands Chemistry Society awards this prize each year to the best Master’s research project. The Master’s thesis must relate to research in the field of chemistry, life sciences, process technology or (bio-)molecular sciences. Deadline: 31-12-2019.read more
Podosome nanoscale architecture redefined20 November 2019
Koen van den Dries and Alessandra Cambi, theme Nanomedicine, revealed how the nanoscale architecture of podosomes enables dendritic cells to protrude and sense their extracellular environment. They have published their results in Nature Communications.read more
270 times Homo Universalis in Nijmegen20 November 2019
What does a scientist of the future look like? International young scientists addressed this important topic during the ENABLE conference, organized by young researchers for young researchers. They showed how the new generation of researchers wants to open up science to the public.read more